Home › Funds › CONGRESS ASSET MANAGEMENT CO › HALO
CONGRESS ASSET MANAGEMENT CO position in HALO
HALOZYME THERAPEUTICS INC · Health Care
CONGRESS ASSET MANAGEMENT CO reported holding 2,281,615 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$251.9M, representing 1.64% of its reported portfolio and ranking #6 among its reported holdings. CONGRESS ASSET MANAGEMENT CO has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How CONGRESS ASSET MANAGEMENT CO's HALO position evolved
CONGRESS ASSET MANAGEMENT CO first disclosed a stake in HALO in Q3 2023 at 303,717 shares (US$11.6M). The position peaked in Q3 2026 at 2,281,615 shares, worth US$251.9M. Across 13 filings, CONGRESS ASSET MANAGEMENT CO increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,281,615 shares valued at US$251.9M — an increase of 1,052,509 shares quarter over quarter.. Notable position changes include a 446% increase in Q3 2024 (shares fell 16% over the following quarter), a 86% increase in Q3 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 303.72K | $11.60M | New |
| Q4 2023 | 351.08K | $12.98M | Add |
| Q1 2024 | 407.87K | $16.59M | Add |
| Q2 2024 | 445.34K | $23.32M | Add |
| Q3 2024 | 2.43M | $139.30M | Add |
| Q4 2024 | 1.96M | $93.69M | Reduce |
| Q1 2025 | 2.13M | $136.09M | Add |
| Q2 2025 | 1.84M | $95.48M | Reduce |
| Q3 2025 | 1.44M | $105.36M | Reduce |
| Q4 2025 | 1.30M | $87.64M | Reduce |
| Q1 2026 | 1.28M | $82.76M | Reduce |
| Q2 2026 | 1.23M | $96.20M | Reduce |
| Q3 2026 | 2.28M | $251.89M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in HALO — the largest reported positions include WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), LOS ANGELES CAPITAL MANAGEMENT LLC (US$151.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M sh · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M sh · $151.69M · Q2 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Stephens Investment Management Group LLC 1.39M sh · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M sh · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M sh · $84.77M · Q2 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
- Mizuho Markets Cayman LP 834.50K sh · $65.32M · Q2 2026
More on CONGRESS ASSET MANAGEMENT CO
FAQ
How long has CONGRESS ASSET MANAGEMENT CO held HALO?
CONGRESS ASSET MANAGEMENT CO has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CONGRESS ASSET MANAGEMENT CO's current position in HALO?
As of Q3 2026, CONGRESS ASSET MANAGEMENT CO holds 2.28M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $251.89M, representing 1.64% of its reported portfolio and ranking #6.
Has CONGRESS ASSET MANAGEMENT CO been buying or selling HALO?
In the latest 13F filing (Q3 2026), CONGRESS ASSET MANAGEMENT CO increased its position in HALO. The position peaked in Q3 2026 at 2.28M shares.
Which other funds hold HALO?
Other major institutional holders of HALO include WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, LOS ANGELES CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.